Connecticut Capital Management Group, LLC

Position in AMGN — Amgen Inc

CIK 2097898 MILFORD, CT

Position in AMGN

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$269,417

-$28,599 QoQ

Shares Held

744

-12.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

#2,627

of 3,140 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Connecticut Capital Management Group, LLC holds $3,815,550 across 6 Drug Manufacturers - General names. AMGN ranks #5 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,039	$1,246,207
2	JNJ	Johnson & Johnson	3,217	$817,020
3	ABBV	AbbVie Inc.	3,151	$792,916
4	MRK	Merck & Co., Inc.	3,415	$438,827
5	AMGN	Amgen Inc This page	744	$269,417
6	GILD	Gilead Sciences, Inc.	1,988	$251,163

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$269,417	744	-12.2%	Shares	Other	2026-07-20
2026-03-31	$298,016	847	+1.0%	Shares	Other	2026-04-13
2025-12-31	$274,613	839	—	Shares	Other	2026-02-09
No filing history on record for this holder in this stock.